Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -28,914 | -22,090 | -40,270 | -100,625 | 21,796 |
| Depreciation Amortization | 4,894 | 4,121 | 5,199 | 6,132 | 5,642 |
| Accounts receivable | 445 | -5,960 | 306 | 682 | -772 |
| Accounts payable and accrued liabilities | 151 | -3,419 | 2,017 | 1,270 | -3,329 |
| Other Working Capital | -2,363 | -7,391 | -138 | -1,670 | -6,437 |
| Other Operating Activity | 31,204 | 41,968 | 42,136 | 104,439 | -3,744 |
| Operating Cash Flow | $5,417 | $7,229 | $9,250 | $10,228 | $13,156 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,135 | -7,528 | -4,839 | -4,215 | -7,094 |
| Purchase Sale Intangibles | -9,718 | -9,863 | -10,229 | -16,548 | -19,492 |
| Other Investing Activity | -9,718 | -9,863 | -11,341 | -17,660 | -20,604 |
| Investing Cash Flow | $-11,853 | $-17,391 | $-16,180 | $-21,875 | $-27,698 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 115,000 |
| Common Stock Issued | N/A | N/A | N/A | 857 | 2,943 |
| Common Stock Repurchased | N/A | -434 | -7,799 | -9,322 | N/A |
| Dividend Paid | N/A | N/A | N/A | N/A | -5,099 |
| Other Financing Activity | -7,529 | -16,438 | -4,844 | -4,890 | -5,324 |
| Financing Cash Flow | $-7,529 | $-16,872 | $-12,643 | $-13,355 | $107,520 |
| Exchange Rate Effect | 88 | -296 | 71 | 158 | -127 |
| Beginning Cash Position | 30,277 | 57,607 | 77,109 | 101,953 | 9,102 |
| End Cash Position | 16,400 | 30,277 | 57,607 | 77,109 | 101,953 |
| Net Cash Flow | $-13,877 | $-27,330 | $-19,502 | $-24,844 | $92,851 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,417 | 7,229 | 9,250 | 10,228 | 13,156 |
| Capital Expenditure | -2,118 | -7,528 | -4,839 | -4,215 | -7,094 |
| Free Cash Flow | 3,299 | -299 | 4,411 | 6,013 | 6,062 |